These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 34754605)

  • 21. New insight of functional molecular imaging into the atheroma biology: 18F-NaF and 18F-FDG in symptomatic and asymptomatic carotid plaques after recent CVA. Preliminary results.
    Quirce R; Martínez-Rodríguez I; Banzo I; Jiménez-Bonilla J; Martínez-Amador N; Ibáñez-Bravo S; López-Defilló J; Jiménez-Alonso M; Revilla MA; Carril JM
    Clin Physiol Funct Imaging; 2016 Nov; 36(6):499-503. PubMed ID: 26147617
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Bhakta S; Chowdhury MM; Tarkin JM; Rudd JH; Warburton EA; Evans NR
    Vasc Med; 2024 Oct; ():1358863X241287692. PubMed ID: 39415512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between carotid
    Fujimoto K; Norikane T; Yamamoto Y; Takami Y; Mitamura K; Okada M; Hatakeyama T; Kawanishi M; Nishiyama Y
    Ann Nucl Med; 2019 Dec; 33(12):907-915. PubMed ID: 31571042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted PET/CT imaging of vulnerable atherosclerotic plaques: microcalcification with sodium fluoride and inflammation with fluorodeoxyglucose.
    Chen W; Dilsizian V
    Curr Cardiol Rep; 2013 Jun; 15(6):364. PubMed ID: 23605466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT).
    Mehta NN; Torigian DA; Gelfand JM; Saboury B; Alavi A
    J Vis Exp; 2012 May; (63):e3777. PubMed ID: 22588186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Update on the Role of Total-Body PET Imaging in the Evaluation of Atherosclerosis.
    Borja AJ; Rojulpote C; Hancin EC; Høilund-Carlsen PF; Alavi A
    PET Clin; 2020 Oct; 15(4):477-485. PubMed ID: 32888546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosing atherosclerosis makes Nuclear Medicine a tissue imaging modality.
    Grammaticos PC
    Hell J Nucl Med; 2014; 17(1):12. PubMed ID: 24701591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is there any complimentary role of F-18 NaF PET/CT in detecting of osseous involvement of multiple myeloma? A comparative study for F-18 FDG PET/CT and F-18 FDG NaF PET/CT.
    Ak İ; Onner H; Akay OM
    Ann Hematol; 2015 Sep; 94(9):1567-75. PubMed ID: 26068066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atherosclerotic plaque metabolism in high cardiovascular risk subjects - A subclinical atherosclerosis imaging study with
    Oliveira-Santos M; Castelo-Branco M; Silva R; Gomes A; Chichorro N; Abrunhosa A; Donato P; Pedroso de Lima J; Pego M; Gonçalves L; Ferreira MJ
    Atherosclerosis; 2017 May; 260():41-46. PubMed ID: 28349887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between age, uptake of
    Arani LS; Gharavi MH; Zadeh MZ; Raynor WY; Seraj SM; Constantinescu CM; Gerke O; Werner TJ; Høilund-Carlsen PF; Alavi A
    Hell J Nucl Med; 2019; 22(1):14-19. PubMed ID: 30843005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imaging atherosclerosis with positron emission tomography.
    Joseph P; Tawakol A
    Eur Heart J; 2016 Oct; 37(39):2974-2980. PubMed ID: 27125951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Usefulness of [
    Sorysz D; Januszek R; Sowa-Staszczak A; Grochowska A; Opalińska M; Bagieński M; Zawiślak B; Dziewierz A; Tokarek T; Krawczyk-Ożóg A; Bartuś S; Dudek D
    J Clin Med; 2021 Jan; 10(3):. PubMed ID: 33499425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammation, Atherosclerosis, and Coronary Artery Disease: PET/CT for the Evaluation of Atherosclerosis and Inflammation.
    Alie N; Eldib M; Fayad ZA; Mani V
    Clin Med Insights Cardiol; 2014; 8(Suppl 3):13-21. PubMed ID: 25674025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimizing an 18F-NaF and 18F-FDG cocktail for PET assessment of metastatic castration-resistant prostate cancer.
    Simoncic U; Perlman S; Liu G; Jeraj R
    Nucl Med Commun; 2015 Dec; 36(12):1174-80. PubMed ID: 26378490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolving Role of PET in Detecting and Characterizing Atherosclerosis.
    Høilund-Carlsen PF; Moghbel MC; Gerke O; Alavi A
    PET Clin; 2019 Apr; 14(2):197-209. PubMed ID: 30826018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of osseous metastasis by 18F-NaF/18F-FDG PET/CT versus CT alone.
    Sampath SC; Sampath SC; Mosci C; Lutz AM; Willmann JK; Mittra ES; Gambhir SS; Iagaru A
    Clin Nucl Med; 2015 Mar; 40(3):e173-7. PubMed ID: 25140557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of NaF and FDG PET/CT for assessment of treatment response in castration-resistant prostate cancers with osseous metastases.
    Simoncic U; Perlman S; Liu G; Staab MJ; Straus JE; Jeraj R
    Clin Genitourin Cancer; 2015 Feb; 13(1):e7-e17. PubMed ID: 25128349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of
    Yellanki DP; Kothekar E; Al-Zaghal A; Cheng N; Werner TJ; Høilund-Carlsen PF; Alavi A
    Hell J Nucl Med; 2018; 21(3):181-185. PubMed ID: 30411728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective comparison of combined 18F-FDG and 18F-NaF PET/CT vs. 18F-FDG PET/CT imaging for detection of malignancy.
    Lin FI; Rao JE; Mittra ES; Nallapareddy K; Chengapa A; Dick DW; Gambhir SS; Iagaru A
    Eur J Nucl Med Mol Imaging; 2012 Feb; 39(2):262-70. PubMed ID: 22065013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging Molecular Targets for Imaging of Atherosclerotic Plaque using Positron Emission Tomography.
    Werner RA; Bengel FM; Derlin T
    Curr Radiopharm; 2021; 14(3):173-183. PubMed ID: 32368992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.